A Phase 1b, Drug-Drug Interaction Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jun 2012
At a glance
- Drugs BMS 986094; Verapamil
- Indications Hepatitis C; Hypertension; Viral infections
- Focus Adverse reactions; Pharmacokinetics
- 31 May 2012 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 31 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 May 2012 Bristol-Myers Squibb added as trial company and lead trial centre as reported by ClinicalTrials.gov.